VSBC (VitaSpring Biomedical Co) ROCE % : -36.17% (As of Oct. 2022)

View and export this data going back to 2019. Start your Free Trial

What is VitaSpring Biomedical Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. VitaSpring Biomedical Co's annualized ROCE % for the quarter that ended in Oct. 2022 was -36.17%.

VitaSpring Biomedical Co ROCE % Historical Data

The historical data trend for VitaSpring Biomedical Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

VitaSpring Biomedical Co ROCE % Chart

VitaSpring Biomedical Co Annual Data

Trend

Jan17

Jan18

Jan19

Jan20

Jan21

Jan22

ROCE %

Get a 7-Day Free Trial

-442.71

138.40

VitaSpring Biomedical Co Quarterly Data
	Jan18	Apr18	Jul18	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22
ROCE %	Get a 7-Day Free Trial															-74.25	326.53	63.08	-31.67	-36.17

VitaSpring Biomedical Co ROCE % Calculation

VitaSpring Biomedical Co's annualized ROCE % for the fiscal year that ended in Jan. 2022 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Jan. 2022 )		(A: Jan. 2021 )		(A: Jan. 2022 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Jan. 2022 )		(A: Jan. 2021 )		(A: Jan. 2022 )
	=	1.483	/	( ( (0.189 - 0.093)	+	(3.604 - 1.557) )	/ 2 )
	=	1.483	/	( (0.096	+	2.047)	/ 2 )
	=	1.483	/	1.0715
	=	138.40 %

VitaSpring Biomedical Co's ROCE % of for the quarter that ended in Oct. 2022 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Oct. 2022 )		(Q: Jul. 2022 )		(Q: Oct. 2022 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Oct. 2022 )		(Q: Jul. 2022 )		(Q: Oct. 2022 )
	=	-0.732	/	( ( (2.585 - 0.506)	+	(2.443 - 0.474) )	/ 2 )
	=	-0.732	/	( ( 2.079	+	1.969 )	/ 2 )
	=	-0.732	/	2.024
	=	-36.17 %

(1) Note: The EBIT data used here is four times the quarterly (Oct. 2022) EBIT data.

VitaSpring Biomedical Co (OTCPK:VSBC) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

VitaSpring Biomedical Co ROCE % Related Terms

Thank you for viewing the detailed overview of VitaSpring Biomedical Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

VitaSpring Biomedical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » VitaSpring Biomedical Co Ltd (OTCPK:VSBC) » Definitions » ROCE %

Comparable Companies

PTCT HRMY VIR BEAM ROCO:6550 CVAC RLAY SHSE:688520 INSM BOM:539268

Traded in Other Exchanges

N/A

Address

400 Spectrum Center Dr. No. 1620, Irvine, CA, USA, 92618

Website

https://www.vitaspringbio.com

VitaSpring Biomedical Co Ltd is a start-up business company. The company's objective is to develop new drugs in cell medicine. The company also plans to produce X.MSC cytopharmaceuticals.

VitaSpring Biomedical Co Headlines

No Headlines